ArticleCureus2025
Challenges of a Pregnant Woman With Untreated Myasthenia Gravis: Delivery and Puerperium.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Myasthenia Gravis and Pregnancy: Clinical Management and Maternal-Neonatal Outcomes.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myasthenia gravis (MG) is a rare autoimmune neurological disorder. Pregnancy, labor, and puerperium are risk factors for a myasthenic crisis. This case reports a late 20s pregnant woman evacuated from Guinea-Bissau with the diagnosis of generalized and severe MG, tetraparetic, at 38 weeks of gestation. She had never been treated for MG. After multidisciplinary assessment and despite current recommendations, intensive therapy with IV immunoglobulin and pyridostigmine was started and labor was induced. There were no neonatal complications. There was a worsening of symptoms during puerperium and therapy intensification with additional corticosteroids being needed. Labor in women with non-treated MG carries a high risk for serious and even fatal complications both for mother and child. Despite being a rare condition, it is more frequent in women of childbearing age, and guidelines on this topic are scarce.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.